IART · Integra Lifesciences Holdings Corp
Market Cap
$1.30B
Shares
77.77M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mojdeh Poul | President and Chief Executive Officer and Director | $9,375,551 |
| Lea Knight | Executive Vice President and Chief Financial Officer | $2,882,994 |
| Harvinder Singh | Executive Vice President, President, International | $1,625,444 |
| Jan De Witte | Former President and Chief Executive Officer and Director | $282,679 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jan De Witte | President and Chief Executive Officer and Director | $7,494,668 |
| Michael McBreen | Executive Vice President, President, Codman Specialty Surgical | $3,160,291 |
| Lea Knight | Executive Vice President and Chief Financial Officer | $3,145,466 |
| Harvinder Singh | Executive Vice President, President, International | $2,624,181 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $2,262,214 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jan De Witte | President and Chief Executive Officer and Director | $6,388,756 |
| Michael McBreen | Executive Vice President, President, Codman Specialty Surgical | $2,830,152 |
| Lea Knight | Executive Vice President and Chief Financial Officer | $1,673,147 |
| Eric I. Schwartz | Executive Vice President, Chief Legal Officer & Secretary | $1,621,620 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,422,883 |
| Jeffrey Mosebrook | Senior Vice President, Finance and Interim PFO | $1,253,294 |
| Carrie Anderson | Former Executive Vice President and Chief Financial Officer | $67,280 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jan De Witte | President and Chief Executive Officer and Director | $9,319,913 |
| Glenn Coleman | Former Executive Vice President and Chief Operating Officer | $4,425,564 |
| Eric I. Schwartz | Executive Vice President, Chief Legal Officer & Secretary | $3,397,306 |
| Carrie Anderson | Former Executive Vice President and Chief Financial Officer | $2,951,694 |
| Michael McBreen | Executive Vice President, President, Codman Specialty Surgical | $2,148,582 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,932,535 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Peter Arduini | President and Chief Executive Officer and Director | $9,839,221 |
| Glenn Coleman | Former Executive Vice President and Chief Operating Officer | $3,537,468 |
| Carrie Anderson | Former Executive Vice President and Chief Financial Officer | $2,636,663 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,957,844 |
| Michael McBreen | Executive Vice President, President, Codman Specialty Surgical | $1,880,367 |
| Jan De Witte | President and Chief Executive Officer and Director | $251,773 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Peter Arduini | President and Chief Executive Officer and Director | $7,740,699 |
| Glenn Coleman | Former Executive Vice President and Chief Operating Officer | $2,827,990 |
| Carrie Anderson | Former Executive Vice President and Chief Financial Officer | $2,060,755 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,365,577 |
| Michael McBreen | Executive Vice President, President, Codman Specialty Surgical | $1,274,273 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Peter Arduini | President and Chief Executive Officer and Director | $7,859,423 |
| Glenn Coleman | Executive Vice President and Chief Operating Officer | $3,120,418 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,390,401 |
| Daniel L. Reuvers | Executive Vice President, President, Codman Surgical Solutions | $1,341,552 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Peter Arduini | President and Chief Executive Officer and Director | $7,647,812 |
| Glenn Coleman | Executive Vice President and Chief Operating Officer | $2,294,670 |
| Daniel L. Reuvers | Executive Vice President, President, Codman Surgical Solutions | $1,818,379 |
| Robert T. Davis | Executive Vice President, President, Tissue Technologies | $1,369,416 |
| Eric I. Schwartz | Executive Vice President, Chief Legal Officer and Secretary | $1,137,220 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Peter Arduini | President and Chief Executive Officer and Director | $7,134,568 |
| Glenn Coleman | Executive Vice President and Chief Operating Officer | $2,287,222 |
| Robert T. Davis | Executive Vice President, President, Orthopedics and Tissue Technologies | $1,434,294 |
| Daniel L. Reuvers | Executive Vice President, President, Codman Surgical Solutions | $1,275,058 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael McBreen | Chief Commercial Officer | Appointed | 2026-05-05 |
| Mojdeh Poul | member of the Company's Board of Directors | Resigned | 2026-05-05 |
| Dr. Stuart M. Essig | President and Chief Executive Officer | Appointed | 2026-05-05 |
Key facts
CIK
917520
CUSIP
457985208
13F (30d)
137 filings
137 filers
Visit website
Investor relations